Wall Street analyst estimates for Waystar Holding Corp. (WAY): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting.
Consensus price target
$32.89 (+14 % vs price $28.85)
between $28.00 and $39.00 · 9 targets published in the last quarter
Closing price, Oct 29
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $1.3B | $1.3B – $1.3B | $1.67 | 13 |
| 2027E | $1.4B | $1.4B – $1.5B | $1.88 | 13 |
| 2028E | $1.6B | $1.5B – $1.9B | $2.18 | 6 |
Figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 1 |
| Buy | 16 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 18 |
| Avg rating (−2 sell to +2 buy) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-02 | $0.41 | ||
| 2026-07-29 | $0.43 | $0.40 | +8.0% |
| 2026-04-29 | $0.42 | $0.39 | +7.7% |
| 2026-02-17 | $0.36 | $0.39 | -7.7% |
| 2025-10-29 | $0.37 | $0.34 | +8.8% |
| 2025-07-30 | $0.36 | $0.33 | +9.1% |
| 2025-04-30 | $0.32 | $0.32 | +0.0% |
| 2025-02-18 | $0.29 | $0.15 | +93.3% |
Valuation Ratios
| P/E Ratio | 41.21 |
| Price / Book | 1.36 |
| EV / EBITDA | 15.91 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $578.6M | $704.9M | $791.0M | $943.5M | $1.10B |
| Cost of Revenue | $151.8M | $214.9M | $249.8M | $315.7M | $348.2M |
| Gross Profit | $426.8M | $490.0M | $541.2M | $627.8M | $751.1M |
| Research & Development | $28.3M | $32.8M | $35.3M | $48.8M | $54.6M |
| Selling, General & Admin | $162.1M | $184.6M | $187.4M | $268.7M | $306.6M |
| Operating Expenses | $366.5M | $400.5M | $399.2M | $504.1M | $501.8M |
| Operating Income | $60.3M | $89.5M | $142.1M | $123.7M | $249.3M |
| EBITDA | $236.4M | $272.6M | $318.6M | $310.4M | $389.9M |
| Interest Expense | $127.0M | $155.3M | $205.9M | $146.3M | $77.5M |
| Pre-tax Income | -$66.7M | -$65.9M | -$63.8M | -$22.5M | $171.8M |
| Income Tax | -$19.6M | -$14.4M | -$12.5M | -$3.4M | $59.7M |
| Net Income | -$47.1M | -$51.5M | -$51.3M | -$19.1M | $112.1M |
| EPS | $-0.28 | $-0.31 | $-0.31 | $-0.13 | $0.63 |
| EPS (Diluted) | $-0.28 | $-0.31 | $-0.31 | $-0.13 | $0.61 |
| Shares Outstanding (Diluted) | 166.7 M | 166.7 M | 166.7 M | 149.9 M | 184.8 M |
Price
| Price | $28.85 (closing price, October 29, 2026) |
| Market Cap | $5.5B |
| Exchange | NASDAQ |
| Country | US |
Related companies: HQY · DOCS · TEM · BTSG · HNGE · HTFL · PRVA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of WAY: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks